Invivyd Alternatives & Competitors
12 companies similar to Invivyd — Vaccines can only take us so far. Antibodies are the natural next step.
Replicate Bioscience, Inc.
The Power of RNA Amplified
San Diego, United States
Rostra Therapeutics
Restore health and save lives through innovative medicines
Glasgow, United Kingdom
AiCuris Anti-infective Cures AG
Delivering Novel Anti-Viral Therapies to Patients with Weakened Immune Systems
Wuppertal, Germany
Mestag Therapeutics
New therapies for inflammatory disease and cancer by targeting fibroblast immunology
London, United Kingdom
Track all Invivyd competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Repertoire Immune Medicines
Repertoire is a biotechnology company creating a new category of immune medicines for canc...
Cambridge, United States
Verdiva Bio
Transforming lives by accelerating innovation in cardiometabolic health
London, United Kingdom
Laronde
Pioneering a completely novel translatable RNA platform - Endless RNA (eRNA)
Cambridge, United States
REGENXBIO
Seeking to improve lives through the curative potential of gene therapy.
Rockville, United States
OMEICOS Therapeutics GmbH
Developing 1st-in-class therapeutics based on the profound understanding of omega-3 fatty...
Berlin, Germany
SanegeneBio
Sanegene Bio is committed to advancing transformative RNAi therapies that address global...
Woburn, United States
Agomab
Ghent, Belgium
CRISPR Therapeutics
Gene-based medicines for patients with serious diseases
Boston, United States
About Invivyd
Vaccines can only take us so far. Antibodies are the natural next step.
Antibody Development, Viral Disease Treatment, Research and Development, Clinical Trials, Education on Antibodies
Healthcare Providers, Patients with Infectious Diseases, Long COVID Patients, Vaccine Injured Individuals, Pharmaceutical Partners
Monoclonal Antibody Development, Virus Evolution Resistance, Proprietary Technology Platform, Emergency Use Authorization, Innovative Antibody Candidates, Antibody-based Therapies, SARS-CoV-2 Treatment, Immunocompromised Protection, Viral Threat Mitigation, Biopharmaceuticals, Integrated Drug Assessment, Antibody Potency Enhancement
B2B, B2D
Product Sales, Licensing, Performance Based
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Invivyd and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Invivyd on 9 Jun 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.